NCT04430855: A reported trial by AbbVie
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04430855 |
|---|---|
| Title | A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adult Subjects With Moderate to Severe Hidradenitis Suppurativa |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 14, 2020 |
| Completion date | April 22, 2021 |
| Required reporting date | April 22, 2024, midnight |
| Actual reporting date | Jan. 10, 2023 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |